-
1
-
-
0012656365
-
-
Edinburgh, Scotland, October
-
World Medical Association. Declaration of Helsinki, 52nd WMA Assembly. Edinburgh, Scotland, October 2000. Available at: http://www.wma.net/e/policy/17- c_e.html. Accessed March 7, 2003; last accessed March 7, 2005.
-
(2000)
Declaration of Helsinki, 52nd WMA Assembly
-
-
-
2
-
-
0030229913
-
Placebo orthodoxy in clinical research II: ethical, legal and regulatory myths
-
B. Freedman, C. Weijer, and K.C. Glass Placebo orthodoxy in clinical research II: ethical, legal and regulatory myths J Law Med Ethics 24 1996 252 259
-
(1996)
J Law Med Ethics
, vol.24
, pp. 252-259
-
-
Freedman, B.1
Weijer, C.2
Glass, K.C.3
-
3
-
-
0028070548
-
The continuing unethical use of placebo controls
-
K.J. Rothman, and K.B. Michels The continuing unethical use of placebo controls N Engl J Med 331 1994 394 398
-
(1994)
N Engl J Med
, vol.331
, pp. 394-398
-
-
Rothman, K.J.1
Michels, K.B.2
-
4
-
-
0025906439
-
Of mice but not men: problems of the randomized clinical trial
-
S. Hellman, and D.S. Hellman Of mice but not men: problems of the randomized clinical trial N Engl J Med 324 1991 1585 1589
-
(1991)
N Engl J Med
, vol.324
, pp. 1585-1589
-
-
Hellman, S.1
Hellman, D.S.2
-
5
-
-
0030228704
-
Placebo orthodoxy in clinical research, I: empirical and methodological myths
-
B. Freedman, C. Weijer, and K.C. Glass Placebo orthodoxy in clinical research, I: empirical and methodological myths J Law Med Ethics 24 1996 243 251
-
(1996)
J Law Med Ethics
, vol.24
, pp. 243-251
-
-
Freedman, B.1
Weijer, C.2
Glass, K.C.3
-
6
-
-
0034687072
-
Placebo-controlled trials and active-control trials in the evaluation of new treatments, part 1: ethical and scientific issues
-
R. Temple, and S.S. Ellenberg Placebo-controlled trials and active-control trials in the evaluation of new treatments, part 1: ethical and scientific issues Ann Intern Med 133 2000 455 463
-
(2000)
Ann Intern Med
, vol.133
, pp. 455-463
-
-
Temple, R.1
Ellenberg, S.S.2
-
7
-
-
0035922438
-
The ethics of placebo-controlled trials - a middle ground
-
E.J. Emanuel, and F.G. Miller The ethics of placebo-controlled trials - a middle ground N Engl J Med 345 2001 915 919
-
(2001)
N Engl J Med
, vol.345
, pp. 915-919
-
-
Emanuel, E.J.1
Miller, F.G.2
-
8
-
-
0037067837
-
Unnecessary use of placebo controls: the case of asthma clinical trials
-
F.G. Miller, and A.F. Shorr Unnecessary use of placebo controls: the case of asthma clinical trials Arch Intern Med 162 2002 1673 1677
-
(2002)
Arch Intern Med
, vol.162
, pp. 1673-1677
-
-
Miller, F.G.1
Shorr, A.F.2
-
9
-
-
0036209675
-
Ethical assessment of industry-sponsored clinical trials: a case analysis
-
F.G. Miller, and A.F. Shorr Ethical assessment of industry-sponsored clinical trials: a case analysis Chest 121 2002 1337 1342
-
(2002)
Chest
, vol.121
, pp. 1337-1342
-
-
Miller, F.G.1
Shorr, A.F.2
-
10
-
-
85120124021
-
Fluticasone vs. placebo in toddlers with asthma: good science or questionable ethics?
-
E.R. Carter Fluticasone vs. placebo in toddlers with asthma: good science or questionable ethics? Chest 122 2002 122 123
-
(2002)
Chest
, vol.122
, pp. 122-123
-
-
Carter, E.R.1
-
13
-
-
0037460848
-
Inhaled glucocorticoids versus leukotriene receptor antagonist as single agent asthma treatment: systematic review of current evidence
-
F.M. Ducharme Inhaled glucocorticoids versus leukotriene receptor antagonist as single agent asthma treatment: systematic review of current evidence BMJ 326 2003 621 623
-
(2003)
BMJ
, vol.326
, pp. 621-623
-
-
Ducharme, F.M.1
-
14
-
-
0038625271
-
A review of once-daily delivery of anti-asthmatic drugs in children
-
J.C. Dubus, and J. Anhoj A review of once-daily delivery of anti-asthmatic drugs in children Pediatr Allergy Immunol 14 2003 4 9
-
(2003)
Pediatr Allergy Immunol
, vol.14
, pp. 4-9
-
-
Dubus, J.C.1
Anhoj, J.2
-
15
-
-
0025828348
-
Clinical trials - are they ethical?
-
E. Passamani Clinical trials - are they ethical? N Engl J Med 324 1991 1589 1592
-
(1991)
N Engl J Med
, vol.324
, pp. 1589-1592
-
-
Passamani, E.1
-
16
-
-
0042093742
-
Estrogen plus progestin and the risk of coronary heart disease
-
J.E. Manson, J. Hsia, K.C. Johnson, J.E. Rossouw, A.R. Assaf, and N.L. Lasser Estrogen plus progestin and the risk of coronary heart disease N Engl J Med 349 2003 523 534
-
(2003)
N Engl J Med
, vol.349
, pp. 523-534
-
-
Manson, J.E.1
Hsia, J.2
Johnson, K.C.3
Rossouw, J.E.4
Assaf, A.R.5
Lasser, N.L.6
-
17
-
-
0035003398
-
Can placebo controls reduce the number of nonresponders in clinical trials?
-
A.C. Leon Can placebo controls reduce the number of nonresponders in clinical trials? Clin Ther 23 2001 596 603
-
(2001)
Clin Ther
, vol.23
, pp. 596-603
-
-
Leon, A.C.1
-
18
-
-
0035938606
-
Long-acting beta-2-agonist monotherapy vs. continued therapy with inhaled corticosteroids in patients with persistent asthma,"
-
S.C. Lazarus, H.A. Boushey, and F.V. Fahy Long-acting beta-2-agonist monotherapy vs. continued therapy with inhaled corticosteroids in patients with persistent asthma," JAMA 285 2001 2583 2593
-
(2001)
JAMA
, vol.285
, pp. 2583-2593
-
-
Lazarus, S.C.1
Boushey, H.A.2
Fahy, F.V.3
-
19
-
-
0035956522
-
Salmeterol and inhaled corticosteroids in patients with persistent asthma
-
J.R. Botkin, E. Clayton, R. Nelson, B. Wilfond, and M.A. Munger Salmeterol and inhaled corticosteroids in patients with persistent asthma JAMA 286 2001 3075
-
(2001)
JAMA
, vol.286
, pp. 3075
-
-
Botkin, J.R.1
Clayton, E.2
Nelson, R.3
Wilfond, B.4
Munger, M.A.5
-
20
-
-
0035956522
-
Salmeterol and inhaled corticosteroids in patients with persistent asthma
-
S.C. Lazarus Salmeterol and inhaled corticosteroids in patients with persistent asthma JAMA 286 2001 3077 3078
-
(2001)
JAMA
, vol.286
, pp. 3077-3078
-
-
Lazarus, S.C.1
-
22
-
-
0023185342
-
Equipoise and the ethics of clinical research
-
B. Freedman Equipoise and the ethics of clinical research N Engl J Med 317 1987 141 145
-
(1987)
N Engl J Med
, vol.317
, pp. 141-145
-
-
Freedman, B.1
-
23
-
-
0036513820
-
When argument fails
-
C. Weijer When argument fails Am J Bioethics 2 2002 10 11
-
(2002)
Am J Bioethics
, vol.2
, pp. 10-11
-
-
Weijer, C.1
-
24
-
-
0036510817
-
What makes placebo-controlled trials unethical?
-
F.G. Miller, and H. Brody What makes placebo-controlled trials unethical? Am J Bioethics 2 2002 3 9
-
(2002)
Am J Bioethics
, vol.2
, pp. 3-9
-
-
Miller, F.G.1
Brody, H.2
-
25
-
-
0037204181
-
The ethics of placebo-controlled trials
-
E.J. Emanuel, and F.G. Miller The ethics of placebo-controlled trials N Engl J Med 346 2002 382 383
-
(2002)
N Engl J Med
, vol.346
, pp. 382-383
-
-
Emanuel, E.J.1
Miller, F.G.2
-
26
-
-
20444497056
-
-
Reference withdrawn
-
[Reference withdrawn]
-
-
-
-
27
-
-
8244232917
-
Nuremberg Code. 1947
-
Simon and Schuster New York
-
Nuremberg Code. 1947 W. Reich Encyclopedia of bioethics 1995 Simon and Schuster New York 2763 2764
-
(1995)
Encyclopedia of bioethics
, pp. 2763-2764
-
-
Reich, W.1
-
28
-
-
0346619699
-
The Belmont report: ethical principles and guidelines for the protection of human subjects of research. 1979
-
W. Reich Macmillan Publishing Co New York
-
National Commission for the Protection of Human Subjects in Biomedical and Behavioral Research The Belmont report: ethical principles and guidelines for the protection of human subjects of research. 1979 W. Reich Encyclopedia of bioethics 1998 Macmillan Publishing Co New York 2767 2773
-
(1998)
Encyclopedia of bioethics
, pp. 2767-2773
-
-
-
30
-
-
85059046830
-
Are placebo-controlled trials safe? An update
-
Presented to the European Respiratory Society, September 1995, Barcelona
-
Kellerman D, Schaberg A, Shah T, et al. Are placebo-controlled trials safe? an update [abstract]. Presented to the European Respiratory Society, September 1995, Barcelona. Ann Allergy Asthma Immunol 1997;79:173-5.
-
(1997)
Ann Allergy Asthma Immunol
, vol.79
, pp. 173-175
-
-
Kellerman, D.1
Schaberg, A.2
Shah, T.3
-
32
-
-
0034694891
-
Helsinki discord? a controversial declaration
-
B. Vastag Helsinki discord? a controversial declaration JAMA 284 2000 2983 2985
-
(2000)
JAMA
, vol.284
, pp. 2983-2985
-
-
Vastag, B.1
-
33
-
-
0036202248
-
Placebo trials and tribulations
-
C. Weijer Placebo trials and tribulations Can Med Assoc J 166 2002 603 604
-
(2002)
Can Med Assoc J
, vol.166
, pp. 603-604
-
-
Weijer, C.1
-
34
-
-
20444450272
-
-
World Medical Association. Note of clarification on paragraph 29. 2002. Available at: http:www.wma.net/e/press.html. Accessed March 7, 2003; last accessed March 7, 2005.
-
(2002)
Note of clarification on paragraph 29
-
-
-
35
-
-
9544235562
-
DHHS regulations for the protection of human subjects. 45 CFR 46, June 18, 1991
-
W. Reich Macmillan Publishing Co New York
-
Department of Health and Human Services DHHS regulations for the protection of human subjects. 45 CFR 46, June 18, 1991 W. Reich Encyclopedia of bioethics 1998 Macmillan Publishing Co New York 2773 2789 at §46.111
-
(1998)
Encyclopedia of bioethics
, pp. 2773-2789
-
-
|